Get Real Time Here
| Open2.220 | Close2.340 |
| Vol / Avg.303.345K / 564.042K | Mkt Cap122.892M |
| Day Range2.190 - 2.415 | 52 Wk Range1.220 - 6.850 |
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Quotes and News Summary
Black Diamond Therapeutic Stock (NASDAQ: BDTX) stock price, news, charts, stock research, profile.
| Open2.220 | Close2.340 |
| Vol / Avg.303.345K / 564.042K | Mkt Cap122.892M |
| Day Range2.190 - 2.415 | 52 Wk Range1.220 - 6.850 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.460 | -0.450 | 0.0100 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.540 | -0.520 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-22 | HC Wainwright & Co. | Robert Burns | Reiterates | BuyBuy | Maintains | - | 11.00 |
| 2023-09-12 | Wedbush | Robert Driscoll | Reiterates | OutperformOutperform | Maintains | - | 10.00 |
| 2023-07-14 | Piper Sandler | Joseph Catanzaro | Initiates Coverage On | Overweight | Announces | - | 11.00 |
| 2023-06-30 | Stifel | Bradley Canino | Upgrades | HoldBuy | Raises | 2.00 | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BDTX | Black Diamond Therapeutic | 9.68% | 122.9M |
| ANIX | Anixa Biosciences | 0.91% | 103.8M |
| VAXX | Vaxxinity | -6.08% | 110.6M |
| GALT | Galectin Therapeutics | 0% | 121.2M |
| CARM | CARISMA Therapeutics | -7.2% | 93.6M |
How do I buy Black Diamond Therapeutic (BDTX) stock?
You can purchase shares of Black Diamond Therapeutic (NASDAQ: BDTX) through any online brokerage.
Who are Black Diamond Therapeutic's (BDTX) competitors?
Other companies in Black Diamond Therapeutic’s space includes: Anixa Biosciences (NASDAQ:ANIX), Vaxxinity (NASDAQ:VAXX), Galectin Therapeutics (NASDAQ:GALT), CARISMA Therapeutics (NASDAQ:CARM) and PepGen (NASDAQ:PEPG).
What is the target price for Black Diamond Therapeutic (BDTX) stock?
The latest price target for Black Diamond Therapeutic (NASDAQ: BDTX) was reported by HC Wainwright & Co. on Wednesday, November 22, 2023. The analyst firm set a price target for 11.00 expecting BDTX to rise to within 12 months (a possible 362.18% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Black Diamond Therapeutic (BDTX)?
The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $2.38 last updated November 30, 2023 at 11:41 PM UTC.
Does Black Diamond Therapeutic (BDTX) pay a dividend?
There is no dividend information for Black Diamond Therapeutic.
When is Black Diamond Therapeutic (NASDAQ:BDTX) reporting earnings?
Black Diamond Therapeutic’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Black Diamond Therapeutic (BDTX) going to split?
There is no upcoming split for Black Diamond Therapeutic.
What sector and industry does Black Diamond Therapeutic (BDTX) operate in?
Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.